The stock of Telomir Pharmaceuticals Inc (NASDAQ: TELO) has decreased by -11.21 when compared to last closing price of 4.64.Despite this, the company has seen a loss of -11.59% in its stock price over the last five trading days. accesswire.com reported 2024-12-23 that MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the “Company”, an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is a promising development as the company explores Telomir-1 for the treatment of Wilson’s disease and other copper related disorders.
Is It Worth Investing in Telomir Pharmaceuticals Inc (NASDAQ: TELO) Right Now?
There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TELO is 17.06M and currently, short sellers hold a 4.69% ratio of that float. The average trading volume of TELO on January 01, 2025 was 164.97K shares.
TELO’s Market Performance
TELO stock saw an increase of -11.59% in the past week, with a monthly gain of 3.52% and a quarterly increase of -30.17%. The volatility ratio for the week is 11.91%, and the volatility levels for the last 30 days are 13.35% for Telomir Pharmaceuticals Inc (TELO). The simple moving average for the past 20 days is -18.59% for TELO’s stock, with a -22.16% simple moving average for the past 200 days.
TELO Trading at -10.15% from the 50-Day Moving Average
After a stumble in the market that brought TELO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.12% of loss for the given period.
Volatility was left at 13.35%, however, over the last 30 days, the volatility rate increased by 11.91%, as shares sank -3.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.34% lower at present.
During the last 5 trading sessions, TELO fell by -11.59%, which changed the moving average for the period of 200-days by -28.10% in comparison to the 20-day moving average, which settled at $5.06. In addition, Telomir Pharmaceuticals Inc saw -17.60% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TELO starting from Bay Shore Trust, who purchase 138,000 shares at the price of $7.00 back on Feb 13 ’24. After this action, Bay Shore Trust now owns 5,455,431 shares of Telomir Pharmaceuticals Inc, valued at $966,000 using the latest closing price.
Stock Fundamentals for TELO
The total capital return value is set at -40.63. Equity return is now at value -1757.27, with -723.88 for asset returns.
Currently, EBITDA for the company is -11.43 million with net debt to EBITDA at 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.74.
Conclusion
In conclusion, Telomir Pharmaceuticals Inc (TELO) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
